These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20077750)

  • 21. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer.
    Bacon CG; Giovannucci E; Testa M; Kawachi I
    J Urol; 2001 Nov; 166(5):1804-10. PubMed ID: 11586228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How much are patients interested in erectile dysfunction treatment after radical prostatectomy?
    Glina S
    Eur Urol; 2008 Mar; 53(3):461-2; discussion 462-4. PubMed ID: 17913338
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality of life outcomes after brachytherapy for early stage prostate cancer.
    Brandeis JM; Litwin MS; Burnison CM; Reiter RE
    J Urol; 2000 Mar; 163(3):851-7. PubMed ID: 10687991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life after radical prostatectomy.
    Liatsikos EN; Assimakopoulos K; Stolzenburg JU
    Urol Int; 2008; 80(3):226-30. PubMed ID: 18480621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quality of life of patients after retropubic radical prostatectomy for prostatic cancer].
    Petrov SB; Rakul SA
    Urologiia; 2006; (1):25-8. PubMed ID: 16550819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Possibilities of surgical therapy in prostatic carcinoma].
    Leisinger HJ; Oswald M
    Ther Umsch; 1995 Jun; 52(6):405-10. PubMed ID: 7541569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment.
    Bhatnagar V; Stewart ST; Huynh V; Jorgensen G; Kaplan RM
    Prostate Cancer Prostatic Dis; 2006; 9(2):136-46. PubMed ID: 16402091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex or surgery--erectile dysfunction after radical treatment of localized prostate cancer.
    Kelović VL; Buković D; Badzek S; Curić Z; Kelović Z; Persec Z; Pavić M
    Coll Antropol; 2009 Jun; 33(2):529-32. PubMed ID: 19662774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quality of life following radical prostatectomy].
    Hodzic J; Jedrusik P; Reckwitz T; Golka K; Schulze H
    Aktuelle Urol; 2003 Sep; 34(5):337-40. PubMed ID: 14566662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introducing a new, simple scoring system to evaluate oncological and functional outcome after radical prostatectomy.
    Salomon L; Anastasiadis A; Saint F; De La Taille A; Chopin D; Abbou CC
    Scand J Urol Nephrol; 2003; 37(5):392-5. PubMed ID: 14594687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current management of erectile dysfunction after cancer treatment.
    Peltier A; van Velthoven R; Roumeguère T
    Curr Opin Oncol; 2009 Jul; 21(4):303-9. PubMed ID: 19509501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Men's experiences following laparoscopic radical prostatectomy: a qualitative descriptive study.
    Milne JL; Spiers JA; Moore KN
    Int J Nurs Stud; 2008 May; 45(5):765-74. PubMed ID: 17482192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to preserve potency and continence in localized prostate cancer.
    Breda G; Celia A
    BJU Int; 2007 Jul; 100 Suppl 2():29-31. PubMed ID: 17594355
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient preferences for outcomes associated with surgical management of prostate cancer.
    Smith DS; Krygiel J; Nease RF; Sumner W; Catalona WJ
    J Urol; 2002 May; 167(5):2117-22. PubMed ID: 11956454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment 'mismatch' in early prostate cancer: do treatment choices take patient quality of life into account?
    Chen RC; Clark JA; Manola J; Talcott JA
    Cancer; 2008 Jan; 112(1):61-8. PubMed ID: 18040996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.